Immunocore Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Immunocore Holdings's past years’ income statements indicate that its last revenue has increased compared to the previous period by 74% to $249,428,000. Profit margin reached -22%. Total operating expenses were $308,040,000.
Profit Margin
| 2018 | 23.65M | -71.63M | -302.82% |
|---|---|---|---|
| 2019 | 25.66M | -103.93M | -404.89% |
| 2020 | 30.11M | -74.09M | -246.04% |
| 2021 | 26.52M | -131.52M | -495.94% |
| 2022 | 143.73M | -41.22M | -28.68% |
| 2023 | 249.42M | -55.28M | -22.17% |
IMCR Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 249.42M | 143.73M | 26.52M | 30.11M | 25.66M | 23.65M |
Cost of revenue | 1.03M | 454K | 73.22M | 74.80M | 99.99M | 0 |
Gross profit | 248.39M | 143.28M | -46.70M | -44.69M | -74.32M | 23.65M |
Operating exp. | ||||||
Research and development | 163.54M | 89.17M | 73.22M | 74.80M | 99.99M | 83.57M |
Selling and marketing | 0 | 0 | 0 | 0 | 99.99M | 83.57M |
Total operating expenses | 308.04M | 182.89M | 161.68M | 119.40M | 144.17M | 117.73M |
Operating income | -59.64M | -39.60M | -135.16M | -86.19M | -118.32M | -93.45M |
Other income (expenses), net | -1.24M | -4.53M | -5.76M | -1.16M | -7.86M | 5.91M |
Income before tax | -60.89M | -44.14M | -140.92M | -87.36M | -126.18M | -88.17M |
Income tax expense | -5.60M | -2.92M | -9.40M | -13.26M | -22.25M | -16.54M |
Net income | -55.28M | -41.22M | -131.52M | -74.09M | -103.93M | -71.63M |
Earnings per share | ||||||
Basic EPS | -1.13 | -0.9 | -3.1 | -2.33 | -3.81 | -2.62 |
Diluted EPS | -1.13 | -0.9 | -3 | -2.33 | -3.81 | -2.62 |
| Data source | Data source | Data source | Data source |